High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan
- 1 September 2003
- journal article
- Published by Elsevier in Journal of Virological Methods
- Vol. 112 (1-2) , 145-151
- https://doi.org/10.1016/s0166-0934(03)00215-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screeningVox Sanguinis, 2003
- Impact of Nucleic Acid Testing for Human Immunodeficiency Virus and Hepatitis C Virus on Blood Product Availability, Outdating, and Patient SafetyArchives of Pathology & Laboratory Medicine, 2002
- Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technologyVox Sanguinis, 2002
- Automated Multiplex Assay System for Simultaneous Detection of Hepatitis B Virus DNA, Hepatitis C Virus RNA, and Human Immunodeficiency Virus Type 1 RNAJournal of Clinical Microbiology, 2001
- Nucleic acid amplification testing of hepatitis B virusThe Lancet, 2000
- TRANSFUSION‐TRANSMITTED HBV AND HCVVox Sanguinis, 1996
- Predictive Value of Screening Tests for Persistent Hepatitis C Virus Infection Evidenced by Viraemia: Japanese ExperienceVox Sanguinis, 1993
- Correlation between Anti‐HBc Titers and HBV DNA in Blood Units without Detectable HBsAgVox Sanguinis, 1992
- Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitisThe Lancet, 1991
- Detection of Australia Antigen by Means of Immune Adherence Haemagglutination TestVox Sanguinis, 1971